newsfilter
← Latest News
PR Newswire·

Theseus Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference

CAMBRIDGE, Mass., Feb. 7, 2023 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) ("Theseus"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the